^
Association details:
| Biomarker: | AR positive |
|---|---|
| Cancer: | Salivary Gland Cancer |
| Drug: | bicalutamide (Androgen receptor inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
…the panel recommends that patients with tumors that are AR+ receive androgen receptor therapy (eg, leuprolide, bicalutamide).
